Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;81(4):984-988.
doi: 10.1016/j.jaad.2019.06.014. Epub 2019 Jun 14.

Reflectance confocal microscopy-guided carbon dioxide laser ablation of low-risk basal cell carcinomas: A prospective study

Affiliations

Reflectance confocal microscopy-guided carbon dioxide laser ablation of low-risk basal cell carcinomas: A prospective study

Cristian Navarrete-Dechent et al. J Am Acad Dermatol. 2019 Oct.

Abstract

Background: Basal cell carcinoma (BCC) treatment modalities can be stratified by tumor subtype and recurrence risk. The main limitation of nonsurgical treatment modalities is the lack of histopathologic confirmation. Reflectance confocal microscopy (RCM) is a noninvasive imaging device that provides quasihistologic images.

Objective: To evaluate the feasibility and efficacy of RCM-guided carbon dioxide (CO2) laser ablation of low-risk BCCs.

Methods: Prospective study with biopsy specimen-proven low-risk BCCs imaged with RCM. RCM was performed on these sites before and after ablation. If residual tumor was found, a new series of laser passes were performed. The patients were then monitored for recurrence clinically and with RCM.

Results: Twenty-two tumor sites in 9 patients (5 men, 4 women) were imaged and treated. Median age was 59 ± 12.9 years (range, 30-74 years). Mean tumor size was 7.7 mm (range, 5-10 mm). Residual tumor was identified in 5 of 22 cases (22.7%) under RCM on immediate first-pass postablation sites, prompting additional laser passes. Median follow-up was 28.5 months (range, 22-32 months) with no recurrences found.

Conclusions: Addition of RCM to laser ablation workflow can detect subclinical persistent tumor after initial ablation and may serve as an aid to increase the efficacy of laser ablation.

Keywords: ablation; basal cell carcinoma; carbon dioxide laser; diagnosis; follow-up; laser; reflectance confocal microscopy; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest:

Milind Rajadhyaksha: he is a former employee of and owns equity in Caliber I.D. (formerly, Lucid Inc.), the company that manufactures and sells a reflectance confocal microscope (VivaScope). The VivaScope, for reflectance confocal microscopy (RCM) imaging, is the commercial version of an original laboratory prototype that was developed by Dr. Rajadhyaksha when he was at Massachusetts General Hospital, Harvard Medical School.

Figures

Figure 1
Figure 1
Reflectance confocal microscopy appearance of aluminium chloride-highlighted basal cell carcinoma tumor nodules (white arrows), immediately after a first pass of laser ablation (no epidermis present). This patient had a second pass of laser ablation showing no residual tumor under RCM (750 × 750 µm).
Figure 2
Figure 2
Superficial basal cell carcinoma on the posterior shoulder of a female in her 50s with metastatic breast cancer. A. Pre-ablation reflectance confocal microscopy (RCM) image showing a suspicious cord-like structures/early tumor nodule with clefting (white arrows) and horizontal vessels (red arrows). Inlet displaying pre-ablation clinical appearance (750 × 750 µm). B. Immediate post ablation RCM showed clear-cut tumor nodules after ablation of the epidermis. These tumor nodules were highlighted by aluminium chloride (white arrow). Reticulated collagen is also seen (yellow arrow). This patient underwent 3 subsequent passes. C. A 12-month RCM follow-up showed scar with dense collagen (yellow arrows); the asterisk corresponds to a hair follicle. Insert showing the appearance of the scar (750 × 750 µm).

Similar articles

Cited by

References

    1. National Comprehensive Cancer Network N. Basal Cell Skin Cancer (Version 1.2018) 2018.
    1. Mirza FN, Khatri KA. The use of lasers in the treatment of skin cancer: A review. J Cosmet Laser Ther 2017;19:451–8. - PubMed
    1. Zane C, Facchinetti E, Arisi M, Ortel B, Calzavara-Pinton P. Pulsed CO2 Laser Ablation of Superficial Basal Cell of Limbs and Trunk: A Comparative Randomized Clinical Trial With Cryotherapy and Surgical Ablation. Dermatol Surg 2017;43:920–7. - PubMed
    1. Telfer NR, Colver GB, Morton CA, British Association of D. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35–48. - PubMed
    1. Kadouch DJ, Schram ME, Leeflang MM, Limpens J, Spuls PI, de Rie MA. In vivo confocal microscopy of basal cell carcinoma: a systematic review of diagnostic accuracy. J Eur Acad Dermatol Venereol 2015;29:1890–7. - PubMed

MeSH terms